BACKGROUND: Atrial fibrillation (AF) has been linked to an inflammatory process detected through various biomarkers, including C-Reactive Protein (CRP). Early recurrence of AF within the first 3 months after curative AF ablation is not felt to reflect success or failure of the procedure. We hypothesized that this early recurrence is due to an inflammatory response to the ablation itself. We therefore sought to evaluate levels of CRP after AF ablation. METHODS: We prospectively enrolled subjects undergoing AF ablation. A control group of patients undergoing ablation for supraventricular tachycardia (SVT) was also enrolled. Each patient had CRP drawn on the day of the procedure (prior to ablation) and during their first follow-up (median 49 days, interquartile range [IQR] 37-93) and second follow-up (median 147 days, IQR 141-257) clinic visits. Patient interviews were performed and medical histories reviewed for evidence of recurrent AF prior to the first follow-up. RESULTS: CRP levels significantly increased from baseline to first follow-up in the AF ablation group (P = 0.0017). CRP did not significantly change after SVT ablation (P = 0.92). Seventeen (45%) of the AF subjects exhibited recurrence of AF prior to first follow-up. After adjusting for multiple potential confounders, AF ablation patients with recurrent AF prior to their first follow-up had a statistically significant greater odds of having an increase in CRP (OR 21, 95% CI 1.1-417, P = 0.045). CONCLUSIONS: AF ablation generates an inflammatory response that persists for several weeks. This inflammation may explain early recurrence of AF after curative ablation.
BACKGROUND:Atrial fibrillation (AF) has been linked to an inflammatory process detected through various biomarkers, including C-Reactive Protein (CRP). Early recurrence of AF within the first 3 months after curative AF ablation is not felt to reflect success or failure of the procedure. We hypothesized that this early recurrence is due to an inflammatory response to the ablation itself. We therefore sought to evaluate levels of CRP after AF ablation. METHODS: We prospectively enrolled subjects undergoing AF ablation. A control group of patients undergoing ablation for supraventricular tachycardia (SVT) was also enrolled. Each patient had CRP drawn on the day of the procedure (prior to ablation) and during their first follow-up (median 49 days, interquartile range [IQR] 37-93) and second follow-up (median 147 days, IQR 141-257) clinic visits. Patient interviews were performed and medical histories reviewed for evidence of recurrent AF prior to the first follow-up. RESULTS:CRP levels significantly increased from baseline to first follow-up in the AF ablation group (P = 0.0017). CRP did not significantly change after SVT ablation (P = 0.92). Seventeen (45%) of the AF subjects exhibited recurrence of AF prior to first follow-up. After adjusting for multiple potential confounders, AF ablation patients with recurrent AF prior to their first follow-up had a statistically significant greater odds of having an increase in CRP (OR 21, 95% CI 1.1-417, P = 0.045). CONCLUSIONS:AF ablation generates an inflammatory response that persists for several weeks. This inflammation may explain early recurrence of AF after curative ablation.
Authors: Kyungmoo Ryu; Li Li; Celeen M Khrestian; Naomichi Matsumoto; Jayakumar Sahadevan; Mary L Ruehr; David R Van Wagoner; Igor R Efimov; Albert L Waldo Journal: Am J Physiol Heart Circ Physiol Date: 2007-04-13 Impact factor: 4.733
Authors: Hakan Oral; Bradley P Knight; Mehmet Ozaydin; Hiroshi Tada; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady Journal: J Am Coll Cardiol Date: 2002-07-03 Impact factor: 24.094
Authors: Hans Kottkamp; Hildegard Tanner; Richard Kobza; Petra Schirdewahn; Anja Dorszewski; Jin-Hong Gerds-Li; Corrado Carbucicchio; Christopher Piorkowski; Gerhard Hindricks Journal: J Am Coll Cardiol Date: 2004-08-18 Impact factor: 24.094
Authors: Ronnier J Aviles; David O Martin; Carolyn Apperson-Hansen; Penny L Houghtaling; Pentti Rautaharju; Richard A Kronmal; Russell P Tracy; David R Van Wagoner; Bruce M Psaty; Michael S Lauer; Mina K Chung Journal: Circulation Date: 2003-11-17 Impact factor: 29.690
Authors: Bor Antolič; Andrej Pernat; Marta Cvijić; David Žižek; Matevž Jan; Matjaž Šinkovec Journal: Wien Klin Wochenschr Date: 2016-06-06 Impact factor: 1.704
Authors: Nitesh A Sood; Guru M Krishnan; Craig I Coleman; Jeffrey Kluger; Moise Anglade; Christopher A Clyne Journal: J Atr Fibrillation Date: 2011-09-30
Authors: Jelena Kornej; Borislav Dinov; Andrew D Blann; Sascha Rolf; Arash Arya; Josephine Schmidl; Daniela Husser; Gerhard Hindricks; Andreas Bollmann; Gregory Y H Lip Journal: PLoS One Date: 2014-11-12 Impact factor: 3.240